Beam Therapeutics Inc (BEAM) — Cash Flow Reinvestment Rate
Beam Therapeutics Inc (BEAM) has a Cash Flow Reinvestment Rate of 0.75x as of December 2023, reinvesting $101.69 Million (capex $3.59 Million plus investments $98.10 Million) from operating cash flow of $135.07 Million. Check Beam Therapeutics Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Beam Therapeutics Inc Cash Flow Reinvestment Rate (2022–2022)
Historical reinvestment intensity for Beam Therapeutics Inc across 1 annual periods. Explore BEAM strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Beam Therapeutics Inc (2022–2022)
Year-by-year capital reinvestment analysis for Beam Therapeutics Inc. For live market cap and broader valuation context, see Beam Therapeutics Inc (BEAM) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 22.65x | $510.29 Million | $22.53 Million | $48.95 Million | — |